Month: September 2022

Big tech and retail giants like Amazon and Walmart joined hundreds of provider groups, hospitals and virtual care companies pressing Congress to take action on telehealth legislation this fall. More than 370 organizations sent a joint letter (PDF) to bipartisan leadership of the U.S. Senate to pass a two-year extension of important telehealth policies enacted at the start ...

Consumers are bombarded with misleading advertising for Medicare Advantage and other health plans. Insurance regulators are taking action to identify and combat the improper marketing of these health plans.

The Inflation Reduction Act is set to lower drug prices for millions of people in the U.S. — but experts fear pharmaceutical companies could exploit loopholes in the bill, ultimately keeping prescription costs high for many. The law takes aim at insulin costs, caps out-of-pocket spending for Medicare beneficiaries, and allows the federal government to ...

With current COVID-19 Supplemental Paid Sick Leave (SPSL) requirements set to expire on September 30, the California Legislature has passed California Assembly Bill 152 (AB 152), which now awaits Governor Gavin Newsom’s signature.

Businesses continue to struggle with ever-rising healthcare costs with 7 in 10 employers expecting moderate to significant increases in what they pay for healthcare benefits over the next three years.

Two weeks after the CDC and FDA authorized Moderna's bivalent omicron booster for emergency use, doses are running out in a few U.S. states.

With 400 to 500 Americans still dying every day of Covid-19, President Biden has declared that “the pandemic is over.”

Have you been wondering whether long COVID was a true post-virus symptom? Now it has been officially confirmed – because researchers have put a price tag on what its costing employer sponsored health plans.

Four pharmaceutical companies have filed hundreds of patents to keep their drugs out of the hands of generic competition and prolong their “unprecedented profits,” according to a report published Thursday. The excessive use of the patent system — by drugmakers Bristol-Myers Squibb, AbbVie, Regeneron and Bayer — keeps the prices of the medications at exorbitant levels, often ...

Blue Shield of California wants its members to get health advice as easily as they can buy sunscreen or toothpaste—and it’s teaming up with Walgreens so they can do all of those things in one place. The insurer and the drugstore giant are launching new Health Corners in 12 Walgreens stores in the San Francisco Bay area ...